ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds

August 1, 1997

In brief: Shalala Meets HIV-Infected Children; Einstein’s Kornblith Moves To PCI; Yang Leaves Center

March 12, 1993

West Coast Symposium Reports Research Progress On Bone Cancer

November 1, 1974

Freireich, Moertel Matched Up Again

February 20, 1981

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999